Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
von Mässenhausen A, Deng M, Billig H, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Göke F, Franzen A, Heasley L, Kirfel J, Brägelmann J, Perner S.
von Mässenhausen A, et al. Among authors: kristiansen g.
Target Oncol. 2016 Oct;11(5):631-642. doi: 10.1007/s11523-016-0431-z.
Target Oncol. 2016.
PMID: 27053219